Decentrialz logo
  • HIPAA Compliant
  • ISO 27001 Certified
Find Trials
About UsContact
Become a Volunteer+1 877 705 1914

Status:

UNKNOWN

Cognitive Abilities in Brain Damaged Patients

Lead Sponsor:

Neuromed IRCCS

Conditions:

Brain Damage

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

The presence of damage to the central and / or peripheral nervous system resulting from pathologies of a different nature (such as multiple sclerosis, Parkinson's disease, dementia, cranial trauma, st...

Detailed Description

The presence of damage to the central and / or peripheral nervous system resulting from pathologies of a different nature (such as multiple sclerosis, Parkinson's disease, dementia, cranial trauma, st...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Males or females aged between 18 and 80;
  • Presence of brain damage resulting from: Multiple Sclerosis, Parkinson Disease, Dementia, Cranial Trauma, Neurosurgical Intervention, Ictus, Epilepsy or Other Neurological Syndromes (for the experimental group only);
  • Absence of neurological disorders (for the control group only);
  • be able to follow the protocol's directions throughout the study;
  • Female subjects undertake not to schedule a pregnancy for the duration of the study;
  • Patients should be able to follow protocol guidelines throughout the study;
  • Patients should be able to understand the aims and risks of the study;
  • Signature of informed consent, approved by our Ethics Committee.
  • Exclusion criteria:
  • Incapability even partial to understand and want;
  • Patients with other pathologies which, according to the opinion of the scientific manager, prevent the recruitment;
  • When using non-invasive brain stimulation techniques or subjects should not submit any of their own contraindications (for further details, see the "Methods" and "Stimulation Evaluation Questionnaire" attached to this proposal);
  • Pregnancy, breastfeeding, and delivery not less than three months before the start of the study.

Exclusion

    Key Trial Info

    Start Date :

    December 15 2017

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2025

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT03344731

    Start Date

    December 15 2017

    End Date

    December 31 2025

    Last Update

    October 31 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    IRCCS Neuromed

    Pozzilli, Isernia, Italy, 86077